Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May-Aug;8(2):37-45.
doi: 10.5005/jp-journals-10008-1159. Epub 2014 Jun 12.

Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I)

Jennifer C Fan Gaskin  1 , Dan Q Nguyen  2 , Ghee Soon Ang  3 , Jeremy O'Connor  4 , Jonathan G Crowston  5
Affiliations
Review

Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Perspectives: The Role of Antifibrotic Agents (Part I)

Jennifer C Fan Gaskin et al. J Curr Glaucoma Pract. 2014 May-Aug.

Abstract

Glaucoma filtration surgery is regularly performed for the treatment of glaucoma and trabeculectomy is often regarded as the 'gold standard' glaucoma operation. The biggest risk of failure of the operation is bleb scarring. The advent of anti-fibrotic agents, such as mitomycin C (MMC) and 5-fluorouracil (5FU) has vastly prolonged the longevity of the bleb, but concerns remain regarding the potential increase in postoperative complications. More selective therapeutic targets have therefore been explored. One of these is vascular endothelial growth factor (VEGF) inhibition. Vascular endothelial growth factor inhi bition has a role not only in sub conjunctival angiogenesis inhi bition but also it has direct anti-fibrotic properties. Newer phar macological compounds and materials have also been developed in recent years in attempt to modulate the wound healing in different ways after glaucoma surgery. These include physical barriers to scarring and vehicles for sustained release of pharmacological agents, and early promising results have been demonstrated. This two-part review will provide a discussion of the application of anti-fibrotic agents in glaucoma filtration surgery and evaluate the newer agents that have been developed. How to cite this article: Fan Gaskin JC, Nguyen DQ, Ang GS, O'Connor J, Crowston JG. Wound Healing Modulation in Glaucoma Filtration Surgery-Conventional Practices and New Pers pectives: The Role of Antifibrotic Agents (Part I). J Curr Glaucoma Pract 2014;8(2):37-45.

Keywords: Antimetabolites; Filtration surgery; Glaucoma; Scarring.; Trabeculectomy; Wound healing modulation.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil

Conflict of interest: None declared

References

    1. Chen CW. Enhanced int raocular pressure cont rolling ef fective ness of trabeculectomy by local application of mitomycin C. Trans Asia-Pacific Acad Ophthalmol. 1983;9:172–177.
    1. Gressel MG, Parrish RK 2nd, Folberg R. 5-fluorouracil and glaucoma filtering surgery: I. An animal model. Ophthal mology. 1984 Apr;91(4):378–383. - PubMed
    1. Cordeiro MF, Schultz GS, Ali RR, Bhattacharya SS, Khaw PT. Molecular therapy in ocular wound healing. Br J Ophthalmol. 1999 Nov;83(11):1219–1224. - PMC - PubMed
    1. Skuta GL, Parrish RK 2nd. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987 Nov-Dec;32(3):149–170. - PubMed
    1. Loon SC, Chew PT. A major review of antimetabolites in glaucoma therapy. Ophthalmologica. 1999;213(4):234–245. - PubMed

LinkOut - more resources